Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**U6 small nuclear RNA 294, pseudogene (RNU6-294P)** is a human non-coding RNA gene classified as a small nuclear RNA pseudogene. Pseudogenes are DNA segments that resemble functional genes but generally lack their known biological activity. RNU6-294P has no known protein product and is not considered a therapeutic target. Its sequence is related to the functional U6 small nuclear RNA, a crucial component of the spliceosome involved in pre-mRNA splicing[3][1]. U6 snRNA pseudogenes such as RNU6-294P are formed through retrotransposon activity (LINE/L1-mediated retrotransposition) but do not themselves participate directly in gene regulatory mechanisms unless proven otherwise[5]. There is currently no evidence that RNU6-294P plays a functional role in disease or serves as a biomarker or drug target[4]. Other non-coding RNA pseudogenes have been shown to regulate their parental genes or participate in microRNA or chromosome structure regulation, but such functions have not been established for RNU6-294P[2].
Not applicable; no known drug targets this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 294, pseudogene (RNU6-294P).